HARMAN Launches New Private Large Language Model for Healthcare Industry- HARMAN HealthGPT

Share this post on:

HARMAN, a subsidiary of Samsung Electronics, has introduced a groundbreaking healthcare-focused Private Language Model (LLM) called HealthGPT. HealthGPT leverages generative AI to provide healthcare professionals, researchers, and institutions with advanced capabilities for patient care, medical research, and decision-making. Here are some key highlights and advantages of HealthGPT:

  1. Natural Language Interaction: HealthGPT offers natural language interaction and learnability, making it user-friendly for healthcare professionals.
  2. Knowledge Base: It has a strong knowledge base derived from various healthcare datasets, enhancing its ability to provide accurate information and insights.
  3. Responsible AI: The model is built on responsible AI principles, ensuring ethical use and responsible handling of healthcare data.
  4. Accuracy and Hallucination Testing: HARMAN has rigorously tested HealthGPT for accuracy and the prevention of hallucinations. Healthcare subject matter experts have validated the results, ensuring the reliability of the model.
  5. Private LLM: HealthGPT is a private LLM, offering enterprises greater control over its use, roadmap, privacy, compliance, and security, all while optimizing costs.
  6. Enhanced Clinical Insights: HealthGPT provides real-time, context-aware clinical insights, assisting healthcare professionals in making informed decisions.
  7. Fine-Tuning Framework: It offers an end-to-end Language Model fine-tuning framework to optimize the model’s performance.
  8. Data Generation Framework: A framework is provided to create high-quality customized datasets, further improving the LLM’s performance.
  9. Automated Evaluation: HealthGPT includes an automated evaluation framework to validate fine-tuned LLMs for output quality, factual accuracy, prevention of hallucinations, and toxicity.
  10. Cost Optimization: Advanced deployment techniques using quantization significantly reduce the model size and processing costs, potentially saving up to 90% in costs.
  11. Drug Discovery and Research: HealthGPT can expedite drug discovery and development by extracting valuable insights from clinical trial data.

Nick Parrotta, President of Digital Transformation Solutions at HARMAN, emphasizes the business value of generative AI and the importance of specialized, domain-specific models to address unique industry challenges. He sees HARMAN HealthGPT as an example of their capability to provide tailored solutions and unlock the potential of generative AI for their clients.

HARMAN has expressed its readiness to apply its expertise in AI and ML to develop more private LLMs for various industries, beyond healthcare, to help organizations solve specific problems and enhance customer value.

Share this post on:

Author: medtechinnovate.com

View all posts by medtechinnovate.com >

Leave a Reply

Your email address will not be published. Required fields are marked *